Peter M Keller (P M Keller)

ResearcherID Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Venues

International journal of molecular sciences

Journal of clinical medicine

Antimicrobial agents and chemotherapy

Scientific reports

University of Zurich

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Zurich Jan 01 2015 - Dec 31 2018

Switzerland

Deputy Head/ Swiss National Centre for Mycobacteria :: Institute of Medical Microbiology

University Hospital Jena Jul 01 2012 - Dec 31 2014

Germany

Resident :: Department of Internal Medicine IV

University Hospital Jena Jan 01 2011 - Jul 31 2012

Germany

Resident :: Institute of Medical Microbiology

University of Zürich Mar 01 2007 - Dec 31 2010

Switzerland

Resident Resarch and Diagnostics :: Institute of Medical Microbiology

Publications

Michael P Brönnimann, Lea Hirzberger, Peter M Keller, Monika Gsell-Albert
Antibacterial Effects of X-ray and MRI Contrast Media: An In Vitro Pilot Study. International journal of molecular sciences 24 (4) (2023)
Michael P Brönnimann, Lea Hirzberger, Peter M Keller, Monika Gsell-Albert
Antibacterial Effects of X-ray and MRI Contrast Media: An In Vitro Pilot Study. International journal of molecular sciences 24 (4) (2023)
Michael P Brönnimann, Lea Hirzberger, Peter M Keller, Monika Gsell-Albert
Antibacterial Effects of X-ray and MRI Contrast Media: An In Vitro Pilot Study. International journal of molecular sciences 24 (4) (2023)
Michael P Brönnimann, Lea Hirzberger, Peter M Keller, Monika Gsell-Albert
Antibacterial Effects of X-ray and MRI Contrast Media: An In Vitro Pilot Study. International journal of molecular sciences 24 (4) (2023)
Michael P Brönnimann, Lea Hirzberger, Peter M Keller, Monika Gsell-Albert
Antibacterial Effects of X-ray and MRI Contrast Media: An In Vitro Pilot Study. International journal of molecular sciences 24 (4) (2023)
Martin Müller, Nadine Sägesser, Peter M Keller, Spyridon Arampatzis, Benedict Steffens, Simone Ehrhard, Alexander Benedikt Leichtle
Urine Flow Cytometry Parameter Cannot Safely Predict Contamination of Urine-A Cohort Study of a Swiss Emergency Department Using Machine Learning Techniques. Diagnostics (Basel, Switzerland) 12 (4) (2022)
Martina L Reichmuth, Rico Hömke, Kathrin Zürcher, Peter Sander, Anchalee Avihingsanon, Jimena Collantes, Chloé Loiseau, Sonia Borrell, Miriam Reinhard, Robert J Wilkinson, Marcel Yotebieng, Lukas Fenner, Erik C Böttger, Sebastien Gagneux, Matthias Egger, Peter M Keller
Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients. Antimicrobial agents and chemotherapy 64 (11) (2020)
Mathieu Clément, Peter M Keller, Odette J Bernasconi, Guido Stirnimann, Pascal M Frey, Guido V Bloemberg, Parham Sendi, Andrea Endimiani
First Clinical Case of In Vivo Acquisition of DHA-1 Plasmid-Mediated AmpC in a Salmonella enterica subsp. enterica Isolate. Antimicrobial agents and chemotherapy 63 (10) (2019)
Frank Imkamp, Francis N Lauener, Daniel Pohl, Philippe Lehours, Filipa F Vale, Quentin Jehanne, Reinhard Zbinden, Peter M Keller, Karoline Wagner
Rapid Characterization of Virulence Determinants in Helicobacter pylori Isolated from Non-Atrophic Gastritis Patients by Next-Generation Sequencing. Journal of clinical medicine 8 (7) (2019)
Francis N Lauener, Frank Imkamp, Philippe Lehours, Alice Buissonnière, Lucie Benejat, Reinhard Zbinden, Peter M Keller, Karoline Wagner
Genetic Determinants and Prediction of Antibiotic Resistance Phenotypes in Helicobacter pylori. Journal of clinical medicine 8 (1) (2019)
K Wagner, B Springer, V P Pires, Peter M Keller
Molecular detection of fungal pathogens in clinical specimens by 18S rDNA high-throughput screening in comparison to ITS PCR and culture. Scientific reports 8 (1) (2018)

Peter M Keller.css-eqlu8i{font-size:small;padding-left:4px;} (P M Keller)

Publication Activity (10 Years)

Top Topics

Top Venues

Peter M Keller (P M Keller)